跳至主要内容
临床试验/JPRN-jRCT1080224832
JPRN-jRCT1080224832已完成Unknown

Assessment of a telemedicine approach in the treatment of Japanese patients with COPD

GSK K.K.0 个研究点目标入组 84 人开始时间: 2019年8月16日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
84

研究概览

简要总结

This study is the first study in which evaluated the usefulness and acceptance of telemonitoring for Japanese patients with COPD for a year. The actual use of telemedicine, the satisfaction and acceptance were collected, evaluated, and shown positive responses not only by patients but also by healthcare providers.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 40age old 至 ot applicable(—)
性别
All

入选标准

  • 1.Participant must be capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the ICF and in this protocol.
  • 2.Participant must be more than 40 years of age inclusive at the time of signing the ICF.
  • 3.An established clinical history of COPD in accordance with the definition by the American Thoracic Society/European Respiratory Society and JRS COPD and ACO guidelines.
  • 4.Participant must be treated with inhaled LAMA and/or LABA as maintenance medication at the screening visit. LAMA/ LABA or ICS combinations will be allowed but inhaled triple therapy (e.g. ICS/LAMA/LABA) will not be allowed at baseline visit. Other short acting bronchodilators, roflumilast, systemic steroids, or antibiotics medications are permitted.
  • 5.Participant may be male or female.
  • 6.Patient who is having a lung function test result within last 12 months prior to study.

排除标准

  • 1.Patients who are unable or unwilling to use the required telemonitoring device/ system.
  • 2.Patients who are treated with ICS/LAMA/LABA triple combination at screening visit or during past 3 months before screening visit even open or closed combinations.
  • 3.Patients who are treated with biologicals during past 6 months before screening visit such as omalizumab or mepolizumab.
  • 4.Pregnancy: Women who are pregnant or lactating or are planning on becoming pregnant during the study.
  • 5.Concurrently participating in another clinical trial, in which the participant has been or will be exposed to an investigational or a non-investigational vaccine/ product (pharmaceutical product)

研究者

发起方
GSK K.K.

相似试验